QA: Renovorx Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001574094_2024_Renovorx_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001574094, Renovorx Inc

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,466,000
4 LiabilitiesCurrent 1,175,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,291,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,729,000
9 ResearchAndDevelopmentExpense 5,667,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,164,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,466,000
1 Liabilities 4,466,000
2 Expenses 11,396,000
3 Revenues 0
4 StockholdersEquity -3,000,000
5 NetIncome -10,232,000
6 ComprehensiveNetIncome -10,232,000
7 BaseVar 9,246,000
8 EconomicCapitalRatiobeforeLimitedLiability -5.65
9 EconomicCapitalRatio 0.109

Edgar->Model Mapping

Feature Distribution

Change over Time